Legal Representation
Attorney
Katherine A. Keating
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 1, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| May 1, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Sep 27, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 2, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 2, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 13, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 28, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 28, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 21, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 18, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations for the treatment of metabolic acidosis associated with chronic kidney disease; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for increasing bicarbonate levels; non-absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders; polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders; non-absorbed polymer for treatment of metabolic acidosis associated with kidney disease
Classification
International Classes
005